Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Boeing stock rises on Bernstein target hike as Delta’s Dreamliner deal keeps focus on deliveries

Boeing stock rises on Bernstein target hike as Delta’s Dreamliner deal keeps focus on deliveries

NEW YORK, Jan 15, 2026, 12:16 EST — Trading in the regular session. Boeing (BA) shares climbed 1.6% to $246.40 by midday Thursday following a price target boost from Bernstein. Analyst Douglas S. Harned maintained a Buy rating and raised the target to $298 from $277, according to MarketScreener data. (MarketScreener) The stock hinges on a straightforward issue: whether Boeing…
Why P&G stock is down today as Procter & Gamble flags a $100 Potemkin mini-tender offer

Why P&G stock is down today as Procter & Gamble flags a $100 Potemkin mini-tender offer

New York, Jan 15, 2026, 11:56 ET — Regular session. Procter & Gamble shares dropped about 1.1% to $144.77 in late morning trade Thursday after the consumer goods giant urged investors to spurn an unsolicited “mini-tender” offer from Potemkin Limited. Potemkin proposed buying up to 50,000 shares at $100 each — roughly 31% below the $145.52 closing price on Dec.…
Applied Materials stock jumps today as TSMC lifts 2026 capex and Barclays upgrades AMAT

Applied Materials stock jumps today as TSMC lifts 2026 capex and Barclays upgrades AMAT

New York, Jan 15, 2026, 11:55 (ET) — Regular session underway. Applied Materials (AMAT.O) jumped 7.8% to $325.41 in late-morning trading Thursday, riding a wave of gains among chip equipment stocks following encouraging factory spending data. Lam Research gained 5.9%, KLA surged 9.0%, and U.S.-listed shares of Taiwan Semiconductor Manufacturing rose 6.9%. TSMC’s announcement to boost 2026 capital spending to…
Why Eli Lilly stock is down today: FDA pushes obesity pill decision to April 10

Why Eli Lilly stock is down today: FDA pushes obesity pill decision to April 10

New York, Jan 15, 2026, 12:06 (EST) — Regular session Eli Lilly and Company shares dropped 4.7% to $1,022.50 on Thursday after Reuters reported that internal documents revealed U.S. regulators delayed a decision on the drugmaker’s weight-loss pill until April 10. A Lilly spokesperson said approval could still come in the second quarter, aligning with current FDA guidance. Holly Fernandez…
ServiceNow stock slides again as Oppenheimer trims target and a security flaw stays in focus

ServiceNow stock slides again as Oppenheimer trims target and a security flaw stays in focus

New York, Jan 15, 2026, 11:32 ET — Regular session ServiceNow shares dropped Thursday following a price target cut from Oppenheimer, adding to the pressure on the workflow software company’s stock, which has struggled to hold steady this month. Shares slipped 1.4% to $132.68 by late morning, after dipping as low as $132.46 earlier. Oppenheimer’s Brian Schwartz cut his price…
IREN stock slips as broker trims forecasts but keeps $80 target

IREN stock slips as broker trims forecasts but keeps $80 target

New York, Jan 15, 2026, 11:52 AM EST — Regular session Shares of IREN Limited dipped Thursday following a downgrade in near-term earnings estimates by H.C. Wainwright. The brokerage, however, maintained its Buy rating and held firm on an $80 price target. (MarketBeat) The pullback is significant since IREN now acts as a high-beta stand-in for two volatile bets: bitcoin-related…
Mastercard stock slips after UK court backs cross-border fee cap plan

Mastercard stock slips after UK court backs cross-border fee cap plan

New York, January 15, 2026, 11:28 EST — Regular session Mastercard shares dropped 0.4% to $544.6 in late morning trading following a UK High Court decision siding with Britain’s payments regulator to cap some cross-border card fees. Visa gained 0.3%, while American Express inched up 0.1%. (Reuters) The decision shines a light on just how much wiggle room the major…
CoreWeave stock jumps as CEO swats down Nvidia “circular financing” talk

CoreWeave stock jumps as CEO swats down Nvidia “circular financing” talk

New York, Jan 15, 2026, 11:30 ET — Regular session Shares of CoreWeave (CRWV) jumped roughly 10% to $98.72 in late morning trading Thursday, fueled by a fresh wave of interest in AI-related stocks. The move came after CEO Michael Intrator addressed concerns about the company’s funding approach, pushing back on investor questions. This move is significant since CoreWeave now…
Salesforce stock drops as Wolfe sticks with $350 target, but AI anxiety still weighs on CRM

Salesforce stock drops as Wolfe sticks with $350 target, but AI anxiety still weighs on CRM

New York, January 15, 2026, 11:27 EST — Regular session Salesforce (CRM) shares were down 1.6% at $235.78 in late morning trade on Thursday, lagging a rise in major U.S. stock ETFs that track the Nasdaq and S&P 500. The pullback matters because investors have turned jumpy on big software names, pressing for signs that new “AI agents” — systems…
BitMine (BMNR) stock slides after $200 million Beast Industries deal as share-vote comes due

BitMine (BMNR) stock slides after $200 million Beast Industries deal as share-vote comes due

New York, Jan 15, 2026, 11:25 EST — Regular session Shares of BitMine Immersion Technologies dropped about 3% Thursday after the company announced a $200 million equity stake in Beast Industries, a creator-driven firm linked to YouTube star MrBeast. Chairman Thomas “Tom” Lee hailed MrBeast as “the leading content creator of our generation,” while Beast CEO Jeff Housenbold called the…
Goldman Sachs stock jumps on earnings beat and dividend hike as traders cash in on volatility

Goldman Sachs stock jumps on earnings beat and dividend hike as traders cash in on volatility

New York, January 15, 2026, 11:21 ET — Regular session Goldman Sachs shares rose nearly 4% on Thursday after the Wall Street bank topped fourth-quarter profit estimates and raised its dividend. The stock was up about 3.9% at $969.24, after closing at $932.67 on Wednesday. The results land as investors comb through bank earnings for signs that last year’s revival…
Johnson & Johnson stock slips as Tecvayli trial data lands ahead of earnings week

Johnson & Johnson stock slips as Tecvayli trial data lands ahead of earnings week

New York, Jan 15, 2026, 11:01 ET — Regular session Johnson & Johnson shares dipped Thursday following fresh late-stage data release for its Tecvayli cancer drug, with investors also bracing for next week’s earnings report. This update is crucial as Johnson & Johnson aims to expand the footprint of its newer drugs while shielding established products from pricing cuts and…
1 240 241 242 243 244 906

Stock Market Today

  • Bitcoin Slides Below Key Support Amid Dollar Strength and Market Fear
    January 31, 2026, 1:56 PM EST. Bitcoin broke below a crucial support level near $83,400, dropping over 9% in a week to trade around $81,200, according to Glassnode onchain data. This decline may lead to further losses toward $80,700, the True Market Mean. The broader crypto market lost 12.4%, triggering the Crypto Fear & Greed Index to signal extreme fear. Despite this, short-term holders at a loss remain under 20%, indicating some resilience. Meanwhile, derivatives markets show cautious speculative sentiment with an increased demand for downside protection, raising the risk of volatility spikes. Crypto analytics firm Santiment notes that extreme bearish sentiment often precedes price recoveries. Bitwise's CIO sees crypto nearing the late stages of a bear-market bottom, suggesting the current negative mood could be temporary.
Go toTop